News Conference News EuroPCR 2025 IVL Effective in Severely Calcified Lesions, Especially in Women Yael L. Maxwell May 22, 2025
News Conference News EuroPCR 2025 Early TAVI Improves Prognosis in Asymptomatic AS No Matter the Extent of Cardiac Damage Yael L. Maxwell May 21, 2025
News Conference News EuroPCR 2023 MITRAL at 5 Years: TMVR for MAC, Failing Devices Shows Ongoing Impact Caitlin E. Cox May 19, 2023
News Conference News EuroPCR 2023 AnchorMan LAAO Device Matches Up Well With the Watchman Todd Neale May 19, 2023
News Conference News EuroPCR 2023 Flushing TAVI Valves With Carbon Dioxide May Protect Against Brain Injury Todd Neale May 16, 2023
News Conference News EuroPCR 2022 Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN Caitlin E. Cox May 27, 2022
News Conference News EuroPCR 2022 MitraClip Helps for Atrial Functional MR: MITRA-TUNE Michael O'Riordan May 19, 2022
News Conference News EuroPCR 2020 ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead Yael L. Maxwell July 03, 2020
News Conference News EuroPCR 2019 Amplatzer Amulet LAA Closure Device Reduces Stroke Through 2 Years: Global Registry Caitlin E. Cox May 31, 2019
News Conference News EuroPCR 2019 BASKET-SMALL 2 Angiographic Substudy Supports Safety of DCBs in Small Coronary Vessels L.A. McKeown May 22, 2019
News Conference News EuroPCR 2019 Drug-Coated Balloons in STEMI ‘Safe and Feasible’ in Specific Circumstances: REVELATION L.A. McKeown May 22, 2019
News Conference News EuroPCR 2018 FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data Caitlin E. Cox May 22, 2018
News Conference News EuroPCR 2016 EWOLUTION Confirms Safety, Efficacy for Real-World Use of Watchman, Even With No Postprocedural Drug Therapy Yael L. Maxwell May 17, 2016
News Conference News EuroPCR 2013 EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges Caitlin E. Cox May 29, 2013
News Conference News EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out May 23, 2011
News Conference News RECLOSE 2-ACS: Poor Responders Show Poor Outcomes Despite Higher Clopidogrel Dose Caitlin E. Cox May 18, 2011